Literature DB >> 1866692

Superior vena cava and central venous reconstruction.

W M Moore1, L H Hollier, T K Pickett.   

Abstract

Partial or complete obstruction of the superior vena cava and its major tributaries occassionally results in incapacitating venous hypertension of the upper extremities and/or head and neck. Factors intrinsic and extrinsic to the central veins play a role in the pathogenesis. The more common causes include mechanically and chemically induced intimal injury with resultant fibrosis, sclerosis, or thrombosis and neoplastic masses with external compression or direct extension in the central venous structures. Medical therapy is indicated in the acute situation and generally allows the time necessary for development of collateral drainage routes. Persistent or progressive symptomatic venous hypertension develops in 5% to 40% of these patients, and approximately 10% of the patients will remain incapacitated. Presented here is a series of 10 patients who underwent reconstruction of the superior vena cava or central veins for incapacitating venous hypertension of the upper extremities and/or head and neck. Reconstruction was accomplished by venous transposition (three patients), externally reinforced ePTFE (six patients), and reversed saphenous vein graft (one patient). No perioperative deaths occurred; however, two late deaths occurred at 3 and 9 months after reconstruction from causes unrelated to the operative procedure. One patient experienced early postoperative graft thrombosis requiring thrombectomy, after which the graft remained patent. All patients had patent grafts and were asymptomatic with respect to their venous disease at the time of preparation of this manuscript, with a mean follow-up period of 30 months. Specific details concerning these 10 cases are discussed and integrated with a focused review of the literature and the historic development of the intraoperative techniques and postoperative care that facilitate the successful management of patients with symptomatic central venous occlusion.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1866692

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  5 in total

1.  Reconstruction of the superior vena cava with the aid of an extraluminal venovenous jugulo-atrial shunt.

Authors:  S Singh; H Sherif; G J Reul
Journal:  Tex Heart Inst J       Date:  2000

2.  High-porosity expanded polytetrafluoroethylene grafts for thoracic vena cava replacement with or without an omentum wrap.

Authors:  T Nishibe; K Yasuda; H Ohkashiwa; S Watanabe; Y Okuda; T Tanabe
Journal:  Surg Today       Date:  2000       Impact factor: 2.549

3.  Coronary artery bypass and superior vena cava syndrome.

Authors:  T V Thomas; K Masrani; J L Thomas
Journal:  Tex Heart Inst J       Date:  1999

4.  Experimental replacement of the thoracic inferior vena cava with a high-porosity expanded polytetrafluoroethylene graft wrapped in an omental pedicle flap.

Authors:  H Ohkashiwa; T Nishibe; S Ohtake; K Miyazaki; H Manase; S Watanabe; T Takahashi; Y Okuda; T Tanabe; H Katoh
Journal:  Surg Today       Date:  1997       Impact factor: 2.540

5.  Superior vena cava syndrome caused by encircling soft tissue.

Authors:  Dae Hyeok Kim; Yong Sun Jeon; Gi Chang Kim; In Sun Ahn; Jun Kwan; Keum Soo Park; Woo Hyung Lee
Journal:  Korean J Intern Med       Date:  2007-06       Impact factor: 2.884

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.